The Bioprocessing Research Industry Club (BRIC) has awarded £3.5 million to researchers at seven UK universities for projects that will make the manufacture of biopharmaceuticals more efficient.
Stem Cell Sciences Plc said it is coordinator of a new collaboration that will design bioassays that can be used to discover new candidates for treating cancer, Alzheimer’s disease, stroke and epilepsy.
GATC Biotech AG, a German DNA sequencing service provider, said it has signed a collaboration agreement with three partners to develop a DNA microarray-based diagnostic test able to detect both bacterial and fungal sepsis-triggering pathogens
Researchers at University College London and Novozymes Delta UK Ltd are working together to develop potential therapeutics for cancer.
German government institutions and private biotech companies are setting up a screening network that is intended to help medical researchers at universities translate their work into potential therapies.
A team of international scientists using data collected from HIV-infected patients in Europe and Australia has identified three polymorphisms that appear to play a role in helping some of these individuals fight infection and delay the onset of AIDS.
UK universities created 187 spin-off companies in the 2005-06 academic year, according to a government survey.
Cambridge Research Biochemicals (CRB) is preparing to investigate a new method for validating antibodies using technology based at Newcastle University and funded by one of the UK’s regional development authorities.
Research into biomarkers for Alzheimer’s disease has shown that plasma is a potentially rich source of these indicators, according to an investigator from King’s College London.